Zeke Capital Advisors, LLC Insulet Corp Transaction History

Zeke Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$186.4 - $279.02 $195,347 - $292,412	-1,048 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$194.8 - $275.7 $44,414 - $62,859	228 Added 27.8%	1,048 $279,000
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $54,127 - $67,477	-212 Reduced 20.54%	820 $218,000
Q2 2021 Aug 16, 2021	SELL	$225.52 - $304.06 $155,383 - $209,497	-689 Reduced 40.03%	1,032 $283,000
Q1 2021 Apr 21, 2021	BUY	$235.95 - $293.05 $36,336 - $45,129	154 Added 9.83%	1,721 $449,000
Q4 2020 Feb 10, 2021	BUY	$215.97 - $265.89 $38,226 - $47,062	177 Added 12.73%	1,567 $401,000
Q2 2020 Jul 21, 2020	SELL	$159.17 - $224.73 $221,087 - $312,149	-1,389 Reduced 49.98%	1,390 $270,000
Q1 2018 May 03, 2018	BUY	$68.49 - $87.2 $190,333 - $242,328	2,779 New	2,779 $241,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.